Ideal candidates will have a demonstrated track record of achievement in computational drug discovery or related areas. Areas of experience relevant to our molecular dynamics-based drug discovery efforts include molecular modeling, fragment-based drug design, cheminformatics, and medicinal chemistry. An ability to leverage experimental data to inform computational approaches would be a plus, as would knowledge of structural biology. Specific knowledge of any of these areas is less critical, however, than strong research skills, and a record of impact in drug discovery. Successful candidates will directly contribute to projects within our expanding portfolio of drug discovery programs, which we pursue both independently and in collaboration with leaders in academia and industry.
The expected annual base salary for this position is $300,000–$450,000. Our compensation package also includes variable compensation in the form of sign-on and year-end bonuses, and generous benefits. The applicable annual base salary paid to a successful applicant will be determined based on multiple factors including the nature and extent of prior experience and educational background.
Please use this form to submit your CV or resume. Inquiries about joining the lab should be directed to Zelimir Galjanic at Zelimir.Galjanic@career.DEShawResearch.com.
D. E. Shaw Research (DESRES) is a privately held biochemistry research company based in New York City. Under the scientific direction of David E. Shaw, the group's chief scientist, D. E. Shaw Research develops technologies for molecular dynamics simulations (including Anton, a massively parallel special-purpose supercomputer, and Desmond, a software package for use on conventional computers and computer clusters) and applies such simulations to b